Welcome to the Vaccine Clinical Trials Program
The Sealy Institute for Vaccine Sciences (SIVS) Clinical Trials Program has been in existence since 2002. Our investigators, research nurses and coordinators are experienced in all phases of vaccine clinical trials from first-in-human Phase I studies
through Phase IV post-marketing studies. Study populations have included premature infants, infants and toddlers, children, adolescents, adults and the elderly.
Clinical trials are the final step in the vaccine development process. The purpose of the SIVS Clinical Trials Program is to conduct these clinical trials, providing the necessary data on vaccine efficacy, immunogenicity and safety in humans.
Below is an overview of the various vaccines for which the SIVS Clinical Trials Program has conducted studies.
Overview of Vaccine Clinical Trial Experience
Other Clinical Trial Experience
Last updated February 11, 2022